SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Evidence of insufficient quality of reporting in patent landscapes in the life sciences
16 references·4 citing·37 second hop
Evidence of insufficient quality of reporting in patent landscapes in the life sciences (2017)Evidence of insufficient quality of repor…Guidelines for Reporting Health Research: A User's Manual (2014)Guidelines for Reporting Heal…Guidelines for reporting health research a user's manual (2014)Guidelines for reporting heal…Patent landscaping for life sciences innovation: toward consistent and transparent practices (2013)Patent landscaping for life s…Are clustering effects accounted for in statistical analysis in leading dental specialty journals? (2012)Are clustering effects accoun…Reporting of Methodologic Information on Trial Registries for Quality Assessment: A Study of Trial Records Retrieved from the WHO Search Portal (2010)Reporting of Methodologic Inf…CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)CONSORT 2010 Statement: updat…The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)The PRISMA statement for repo…Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred Reporting Items for…Avoidable waste in the production and reporting of research evidence (2009)Avoidable waste in the produc…What is missing from descriptions of treatment in trials and reviews? (2008)What is missing from descript…The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies (2007)The Strengthening the Reporti…Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials (2004)Empirical Evidence for Select…The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist (2002)The reporting of methodologic…Journal impact factor: a brief review. (1999)Journal impact factor: a brie…Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995)Empirical evidence of bias. D…Empirical Evidence of Bias (1995)Empirical Evidence of BiasWhat, Where, When and How of COVID-19 Patents Landscape: A Bibliometrics Review (2022)What, Where, When and How of …Patent intelligence of RNA viruses: Implications for combating emerging and re-emerging RNA virus based infectious diseases (2022)Patent intelligence of RNA vi…Improving transparency and reproducibility of patent landscapes: the Reporting Items for Patent Landscapes (RIPL) statement and other considerations (2020)Improving transparency and re…Synthetic Biology - Mapping the Patent Landscape (2018)Synthetic Biology - Mapping t…Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)Rayyan—a web and mobile app for systematic reviews (2016)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Improving the quality of reporting of randomized controlled trials. The CONSORT statement (1996)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Avoidable Waste in the Production and Reporting of Research Evidence (2009)A refined taxonomy of behaviour change techniques to help people change their physical activity and healthy eating behaviours: The CALO-RE taxonomy (2011)Behaviour change techniques: the development and evaluation of a taxonomic method for reporting and describing behaviour change interventions (a suite of five studies involving consensus methods, randomised controlled trials and analysis of qualitative data) (2015)The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials (2001)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis (2007)Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry (2008)CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)Measuring inconsistency in meta-analyses (2003)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? (2020)Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis (2020)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials (2013)Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration (2015)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)Bias in meta-analysis detected by a simple, graphical test (1997)Cochrane Handbook for Systematic Reviews of Interventions (2008)Impact factor: a valid measure of journal quality? (2003)A Principal Component Analysis of 39 Scientific Impact Measures (2009)Application of bibliometrics in medicine: a historical bibliometrics analysis (2020)Reducing waste from incomplete or unusable reports of biomedical research (2014)CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts (2017)The COMET Handbook: version 1.0 (2017)CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)
this work references cited by second hop

References

  • 2009Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement37,549 cited
  • 2007The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies21,132 cited
  • 2009The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration17,627 cited
  • 2010CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials9,314 cited
  • 1995Empirical Evidence of Bias5,632 cited
  • 1995Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials5,560 cited
  • 2009Avoidable waste in the production and reporting of research evidence2,204 cited
  • 2004Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials1,845 cited
  • 1999Journal impact factor: a brief review.760 cited
  • 2008What is missing from descriptions of treatment in trials and reviews?613 cited
  • 2002The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist167 cited
  • 2014Guidelines for Reporting Health Research: A User's Manual144 cited
  • 2014Guidelines for reporting health research a user's manual118 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2012Are clustering effects accounted for in statistical analysis in leading dental specialty journals?65 cited
  • 2013Patent landscaping for life sciences innovation: toward consistent and transparent practices58 cited
  • 2010Reporting of Methodologic Information on Trial Registries for Quality Assessment: A Study of Trial Records Retrieved from the WHO Search Portal47 cited
  • Cited by

    • 2020Improving transparency and reproducibility of patent landscapes: the Reporting Items for Patent Landscapes (RIPL) statement and other considerations13 cited
    • 2022Patent intelligence of RNA viruses: Implications for combating emerging and re-emerging RNA virus based infectious diseases10 cited
    • 2022What, Where, When and How of COVID-19 Patents Landscape: A Bibliometrics Review9 cited
    • 2018Synthetic Biology - Mapping the Patent Landscape8 cited